Thomson Reuters Foundation

Inform - Connect - Empower

Bolivia says re-admitted to UN drug convention on its own terms

Source: Thomson Reuters Foundation - Sat, 12 Jan 2013 03:28 GMT
Author: Reuters
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

LA PAZ, Jan 11 (Reuters) - Bolivia on Friday said it had been re-admitted to the U.N. anti-narcotics convention after persuading member states to recognize the right of its indigenous people to chew raw coca leaf, which is used in making cocaine.

President Evo Morales had faced opposition from Washington in his campaign against the classification of coca as an illicit drug.

"The coca leaf has accompanied indigenous peoples for 6,000 years," said Dionisio Nunez, Bolivia's deputy minister of coca and integrated development. "Coca leaf was never used to hurt people. It was used as medicine."

The leaf was declared an illegal narcotic in the 1961 U.N. Single Convention on Narcotic Drugs, along with cocaine, heroin, opium and morphine and a host of chemical drugs.

Bolivia withdrew from the convention a year ago and said it would not rejoin unless coca chewing was decriminalized.

Opposition came from the United States as well as France and Russia. Bolivia said it automatically rejoined the convention when a deadline ran out for opposing countries to block its petition for readmission with coca chewing permitted.

The country is the biggest cocaine producer after Peru and Colombia. But Morales, himself a former coca leaf farmer, says the plant offers health benefits.

Bolivians have chewed raw coca leaves for centuries as a mild stimulant that reduces hunger and altitude sickness. (Reporting By Daniel Ramos; Writing by Hugh Bronstein; Editing by Xavier Briand)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus